Showing 621-630 of 1612 results for "".
Almirall/Allergan, LEO/Bayer Deals
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-almirall-allergan-leo-bayer-deals/18240/Leo Pharma has agreed to acquire Bayer's global prescription dermatology unit, and Almirall will acquire Allergan's US portfolio of medical dermatology drugs. When it comes to patient engagement, aesthetic practices often have the right mindset, but they may lack the skills or time necessary to execCase Study: Recurrent Generalized Pustular Psoriasis
https://practicaldermatology.com/issues/august-2025/recurrent-generalized-pustular-psoriasis/36711/This article reports the case of a 74-year-old white man with a history of psoriatic arthritis and congestive heart failure who presented with two separate episodes of GPP. Both of these episodes were associated with hypocalcemia and required inpatient hospitalization.DermWireTV: Latest on Galderma, Eczema Awareness, Hacking Derm, and More
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-latest-on-galderma-eczema-awareness-hacking-derm-and-more/19675/In this week’s edition: Galderma’s Aklief (trifarotene) topical cream is now approved for acne. Sandra Johnson, MD weighs in. Supported by Sanofi and Regeneron in partnership with the National Eczema Association, the Understand AD Squad includes dermatologist Mercedes Gonzalez, MD, who discusses herGalderma's Future, Allergan's Bonti Buy, and Sebacia Clearance
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-s-future-allergan-s-bonti-buy-and-sebacia-clearance--xgheloga/18233/Nestle's Board says it has come to the conclusion that the future growth opportunities of Nestlé Skin Health lie increasingly outside the Group's strategic scope and expects a review of strategic options for Nestlé Skin Health to be complete by mid-2019. Allergan is acquiring Bonti for 195 million dABD Eyes Mohs Certification, Sun's Ilumya Approved, FUE Update
https://practicaldermatology.com/topics/psoriasis/dermwiretv-abd-eyes-mohs-certification-sun-s-ilumya-approved-fue-update/18319/The American Board of Dermatology has notified the American Board of Medical Specialties it wants to offer a subspecialty certificate in Micrographic Dermatologic Surgery. Dermatologists react. Ilumya or tildrakizumab from Sun Pharma is approved for moderate to severe psoriasis. Medicine the MusicalA Case of Pityriasis Lichenoides; Low-Tech/High-Yield Tech Solutions
https://practicaldermatology.com/topics/general-topics/a-case-of-pityriasis-lichenoides-low-techhigh-yield-tech-solutions/20537/Case Report: A 61-year-old man with Pityriasis LichenoidesThe Role of Inflammation in Acne Vulgaris
https://practicaldermatology.com/topics/general-topics/the-role-of-inflammation-in-acne-vulgaris/21512/Multiple lines of evidence support a pivotal role for inflammation in the pathogenesis of acne vulgaris.Addressing the Relationship Between Depression and Skin Disease
https://practicaldermatology.com/topics/general-topics/PD1208_03-php/22601/Dermatologists aren't expected to be psychotherapists, but they must be prepared to refer high-risk patients and to offer therapeutic support and understanding to others.Taking the Leap Into Private Practice
https://practicaldermatology.com/programs/practical-dermatology/taking-the-leap-into-private-practice/24042/Practice is hard. Private practice is even harder.The Elephant In The Exam Room: Emerging Dermatology Qualifications of Different Stripes and Types
https://practicaldermatology.com/topics/practice-management/the-elephant-in-the-exam-room-emerging-dermatology-qualifications-of-different-stripes-and-types/23681/How can professionals of varying backgrounds support evolving educational standards and promote each other’s unique faculties?